Skip to content
CityAM Canada
  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities
Tuesday 28 July 2026 3:00 pm

Clinisys Partners with Decisions to Bring Low-Code / No-Code LIMS/LIS Configuration to Laboratory Environments

By: Business Wire

Add as a preferred source on Google

Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform. Together, the companies will deliver a new approach to laboratory information management system (LIMS) configuration — empowering laboratories to adapt systems more efficiently without compromising control or regulatory requirements.

Laboratories today operate in an environment defined by rising complexity, regulatory pressure, and increasing demand for speed. Traditional LIMS/LIS configuration approaches often rely heavily on development resources, creating bottlenecks that slow change and limit operational agility.

Through this partnership, Clinisys is integrating Decisions’ low-code and no-code orchestration, automation, and advanced AI capabilities into its platform. These capabilities enable laboratories to design, adapt, and manage workflows using visual tools and reusable components. The collaboration marks a significant new approach in how laboratories across life sciences, healthcare, public health, environmental testing, food & beverage, toxicology, and manufacturing industries can adapt and evolve digital systems.

By embedding a powerful low-code and no-code engine directly within the Clinisys™ Platform, lab leaders gain the ability to build, modify, and optimize workflows with more efficiency and speed—within a structured and controlled framework—without relying on proprietary languages or vendor-restricted development tools.

“Laboratories don’t need more features; they need flexible ways to adapt workflows as their operational requirements evolve beyond traditional, code-heavy paradigms,” said Shay Hassidim, Clinisys Chief Technology Officer. “This partnership puts configuration control and advanced AI tools into the hands of the laboratory, enabling teams to design and adjust workflows through visual tools while maintaining the structure, governance, and performance they require.”

Decisions provides a unified platform for workflow automation, rules management, and integration—allowing organizations to design and orchestrate complex processes without writing code.

Clinisys’s laboratory domain expertise combined with Decisions enables laboratories to:

  • Support implementation and system changes
  • Reduce dependency on custom development and specialized expertise
  • Support regulatory compliance and traceability
  • Scale workflows across evolving testing requirements

“Laboratories are managing increasingly complex, rules-driven processes and those processes need to evolve alongside the science itself,” said Decisions CEO Giles Whiting. “By bringing together Clinisys’s laboratory expertise with our orchestration and rules platform, we’re enabling organizations to adapt workflows more efficiently while keeping decision logic clear, consistent, and scalable.”

This partnership supports an approach to laboratory-controlled configuration, in which systems can evolve with operational requirements while remaining structured, auditable, and traceable.

To learn more, request the white paper here:

“Rethinking LIMS/LIS Configuration: A Low-Code / No-Code Path to Laboratory Agility.”

About Clinisys

Clinisys is a global provider of intelligent laboratory informatics solutions that support a healthier and safer world. Serving healthcare, life sciences, and public health customers, Clinisys is headquartered in Tucson, Arizona; Raleigh, NC; Woking, England; and Ghent, Belgium. Millions of laboratory results and data insights are generated every day using Clinisys’s platform and cloud-based solutions in over 7,000 laboratories across 42 countries.

Clinisys – Enabling healthier and safer communities.

To learn more, visit: www.clinisys.com

About Decisions

Decisions is the control layer for enterprise AI, bringing AI agents, systems, and people together under centralized governance. Built on a foundation of decisioning, workflow orchestration, and process automation, it transforms fragmented automation into orchestrated outcomes across the business. Trusted by enterprises globally, Decisions helps organizations execute with speed, visibility, and control. Learn more about Decisions at https://www.decisions.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20260728669370/en/

Contact

Media Contact

Michele Schicchi
SVP, Global Marketing and Corporate Communications, CMO
Clinisys
Michele.Schicchi@clinisys.com

Company Logo
Company Logo
Read more

Clinisys™ Advances Its Unified Laboratory Platform With Clinisys™ Laboratory Solution (CLS) v2025.3

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Contract/Agreement
  • Product/Service

Trending Articles

  • Big Four’s AIM exodus accelerates as mid-tier firms seize mandates

  • FTSE 100 firm agrees £5.7bn takeover in latest private equity swoop

  • Burnham backs plan to pump £1bn pension funds into start-ups

  • FTSE 100 Live: Stocks jump as oil drops; Unilever shares soar on decade-best sales

  • Scotland’s tax hike may have backfired as receipt falls

More from CityAM

  • Clinisys™ Advances Its Unified Laboratory Platform With Clinisys™ Laboratory Solution (CLS) v2025.3

    Business Wire
  • Metapack® Named OneStock’s Strategic Delivery Management Partner

    Business Wire
  • FlexTrade Expands Portfolio Risk and Analytics Capabilities Through Strategic Partnership with Portx

    Business Wire
  • ROYC and PwC Sweden Collaborate to Digitalize Private Equity Structuring & Fund Operations

    Business Wire
  • Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

    Business Wire
  • Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group

    Business Wire
  • Presidio Investors Announces Sale of ElevATE Semiconductor to Diodes Incorporated

    Business Wire
  • Rehlko Announces €12 Million Expansion of Power Control & Distribution Manufacturing Facility in Cholet, France

    Business Wire

CityAM Canada — business, markets and opinion for Canadian readers.

Published by CityAM Publishing
3 Borden Street #301, Toronto, Ontario M5S 2M8, Canada
Contact us ›

Sections

  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities

Company

  • About
  • Newsroom
  • Contact

Legal

  • Editorial Policy
  • Corrections Policy
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 CityAM Canada. All rights reserved.
Terms · Privacy · Cookies